{"schema_version":"secwatch.filing_event.v1","accession":"0001730463-24-000099","form_type":"8-K","ticker":"AUTL","cik":"0001730463","company_name":"Autolus Therapeutics plc","filed_at":"2024-09-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.343020+00:00","generated_at":"2026-05-31T04:57:46.767749+00:00","sec_items":["1.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Autolus secures up to £18.5M landlord funding for Nucleus facility clean rooms","bullets":["Landlord provides up to £18.5M for improvements to Stevenage manufacturing facility.","Annual rent will increase by ~£1.84M after improvements, capped at £2.19M.","Lease term unchanged through September 2043.","Amendments approved by audit committee due to director's familial relationship with landlord's parent executive."],"urls":{"canonical":"https://secwatch.observer/filing/0001730463-24-000099","json":"https://secwatch.observer/filing/0001730463-24-000099.json","markdown":"https://secwatch.observer/filing/0001730463-24-000099.md","text":"https://secwatch.observer/filing/0001730463-24-000099.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1730463/000173046324000099/0001730463-24-000099-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1730463/000173046324000099/autl-20240910.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T04:57:46.767749+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}